NCT05795062View on ClinicalTrials.gov

Treatment Patterns Among Patients With Venous Thromboembolism in the United States

CompletedOBSERVATIONAL

Enrollment

13,945

Participants

Timeline

Start Date

March 10, 2023

Primary Completion Date

September 30, 2023

Study Completion Date

September 30, 2023

Conditions

Venous Thromboembolism

Interventions

DRUG

apixaban

patients treated with apixaban

DRUG

warfarin

patients treated with warfarin

Trial Locations (1)

10017

Pfizer, New York

Sponsors

Lead Sponsor

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Pfizer

INDUSTRY